Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review
Background: The tumor marker ‘cancer antigen 125’ (CA-125) plays a role in the management of women with advanced stage ovarian cancer. This study aims to describe the predictive value of pre-treatment CA-125 level and the reduction after neoadjuvant chemotherapy (NACT) on surgical outcome. Methods:...
Main Authors: | Puck E. Brons, Gatske M. Nieuwenhuyzen-de Boer, Christian Ramakers, Sten Willemsen, Malika Kengsakul, Heleen J. van Beekhuizen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/23/5734 |
Similar Items
-
The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01) -
CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
by: Wang Fang, et al.
Published: (2013-02-01) -
Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
by: Elham Saffarieh, et al.
Published: (2022-08-01) -
Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01) -
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study
by: Gatske M. Nieuwenhuyzen-de Boer, et al.
Published: (2022-12-01)